U.S. patent court rejects Alvogen’s challenge for Celgene’s Revlimid – Yahoo Finance

U.S. patent court rejects Alvogen’s challenge for Celgene’s Revlimid  Yahoo Finance

A U.S. administrative court on Thursday rejected a filing by Alvogen Pine Brook Llc for a review challenging patents on Celgene Corp’s blockbuster myeloma …